Supplementary materials for the manuscript "Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population" Article Swipe

View

Aya Kawasaki , Ken‐ei Sada , Premita Ari Kusumawati , Fumio Hirano , S Kobayashi , Kenji Nagasaka , Takahiko Sugihara , Nobuyuki Ono , Takashi Fujimoto , Makio Kusaoi , Naoto Tamura , Yasuyoshi Kusanagi , Kenji Itoh , Takayuki Sumida , Kunihiro Yamagata , Hiroshi Hashimoto , Hirofumi Makino , Yoshihiro Arimura , Masayoshi Harigai , Naoyuki Tsuchiya ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.6084/m9.figshare.21876159.v2

Supplementary Table S1. Association analysis of each HLA-DRB1 allele with occurrence of relapse and time to relapse. Supplementary Table S2. Association analysis of each HLA-DQA1 allele with occurrence of relapse and time to relapse. Supplementary Table S3. Association analysis of each HLA-DQB1 allele with occurrence of relapse and time to relapse. Supplementary Table S4. Association analysis of each HLA-DPB1 allele with occurrence of relapse and time to relapse. Supplementary Figure S1. Sanger sequencing chromatograms around the HLA-DQA1*03:02 tagSNP rs11545686. Representative Sanger sequencing chromatograms corresponding to each of the three genotypes are shown. The rs11545686C allele tags HLA-DQA1*03:02. HLA-DQA1 genotype of each subject determined by PCR-SSOP was DQA1*03:02/03*02 (relapse ID 36), DQA1*03:02/05:07 (relapse ID 156) and DQA1* 01:01/01:02 (relapse ID 164), as shown in Supplementary Data 1. Supplementary Data 1. Clinical information and HLA genotypes in each subject examined for susceptibility and relapse. Susceptibility Data 2. Association of each HLA -class II amino acid with relapse-free survival.

Related Topics

Anti-Neutrophil Cytoplasmic Antibody

Concepts

Anti-neutrophil cytoplasmic antibody Myeloperoxidase Allele Human leukocyte antigen Vasculitis Medicine Immunology Population Genetics Internal medicine Biology Antigen Gene Inflammation Disease Environmental health

Metadata

Type: dataset
Language: en
Landing Page: https://doi.org/10.6084/m9.figshare.21876159.v2
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4394251994

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4394251994

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.6084/m9.figshare.21876159.v2

Digital Object Identifier
Title: Supplementary materials for the manuscript "Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population"

Work title
Type: dataset

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-01-01

Full publication date if available
Authors: Aya Kawasaki, Ken‐ei Sada, Premita Ari Kusumawati, Fumio Hirano, S Kobayashi, Kenji Nagasaka, Takahiko Sugihara, Nobuyuki Ono, Takashi Fujimoto, Makio Kusaoi, Naoto Tamura, Yasuyoshi Kusanagi, Kenji Itoh, Takayuki Sumida, Kunihiro Yamagata, Hiroshi Hashimoto, Hirofumi Makino, Yoshihiro Arimura, Masayoshi Harigai, Naoyuki Tsuchiya

List of authors in order
Landing page: https://doi.org/10.6084/m9.figshare.21876159.v2

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.6084/m9.figshare.21876159.v2

Direct OA link when available
Concepts: Anti-neutrophil cytoplasmic antibody, Myeloperoxidase, Allele, Human leukocyte antigen, Vasculitis, Medicine, Immunology, Population, Genetics, Internal medicine, Biology, Antigen, Gene, Inflammation, Disease, Environmental health

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4394251994
doi	https://doi.org/10.6084/m9.figshare.21876159.v2
ids.doi	https://doi.org/10.6084/m9.figshare.21876159.v2
ids.openalex	https://openalex.org/W4394251994
fwci
type	dataset
title	Supplementary materials for the manuscript "Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population"
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10697
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9994000196456909
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2740
topics[0].subfield.display_name	Pulmonary and Respiratory Medicine
topics[0].display_name	Vasculitis and related conditions
topics[1].id	https://openalex.org/T11597
topics[1].field.id	https://openalex.org/fields/24
topics[1].field.display_name	Immunology and Microbiology
topics[1].score	0.9972000122070312
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/2403
topics[1].subfield.display_name	Immunology
topics[1].display_name	Neutrophil, Myeloperoxidase and Oxidative Mechanisms
topics[2].id	https://openalex.org/T14015
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9907000064849854
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2745
topics[2].subfield.display_name	Rheumatology
topics[2].display_name	Otitis Media and Relapsing Polychondritis
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C24040308
concepts[0].level	4
concepts[0].score	0.7843469381332397
concepts[0].wikidata	https://www.wikidata.org/wiki/Q574727
concepts[0].display_name	Anti-neutrophil cytoplasmic antibody
concepts[1].id	https://openalex.org/C203565725
concepts[1].level	3
concepts[1].score	0.7045552730560303
concepts[1].wikidata	https://www.wikidata.org/wiki/Q420012
concepts[1].display_name	Myeloperoxidase
concepts[2].id	https://openalex.org/C180754005
concepts[2].level	3
concepts[2].score	0.6580836772918701
concepts[2].wikidata	https://www.wikidata.org/wiki/Q80726
concepts[2].display_name	Allele
concepts[3].id	https://openalex.org/C188280979
concepts[3].level	3
concepts[3].score	0.6099387407302856
concepts[3].wikidata	https://www.wikidata.org/wiki/Q911125
concepts[3].display_name	Human leukocyte antigen
concepts[4].id	https://openalex.org/C2776015282
concepts[4].level	3
concepts[4].score	0.5839023590087891
concepts[4].wikidata	https://www.wikidata.org/wiki/Q644318
concepts[4].display_name	Vasculitis
concepts[5].id	https://openalex.org/C71924100
concepts[5].level	0
concepts[5].score	0.5176210999488831
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[5].display_name	Medicine
concepts[6].id	https://openalex.org/C203014093
concepts[6].level	1
concepts[6].score	0.5101009011268616
concepts[6].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[6].display_name	Immunology
concepts[7].id	https://openalex.org/C2908647359
concepts[7].level	2
concepts[7].score	0.45531803369522095
concepts[7].wikidata	https://www.wikidata.org/wiki/Q2625603
concepts[7].display_name	Population
concepts[8].id	https://openalex.org/C54355233
concepts[8].level	1
concepts[8].score	0.2462717890739441
concepts[8].wikidata	https://www.wikidata.org/wiki/Q7162
concepts[8].display_name	Genetics
concepts[9].id	https://openalex.org/C126322002
concepts[9].level	1
concepts[9].score	0.22911453247070312
concepts[9].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[9].display_name	Internal medicine
concepts[10].id	https://openalex.org/C86803240
concepts[10].level	0
concepts[10].score	0.200630784034729
concepts[10].wikidata	https://www.wikidata.org/wiki/Q420
concepts[10].display_name	Biology
concepts[11].id	https://openalex.org/C147483822
concepts[11].level	2
concepts[11].score	0.15463414788246155
concepts[11].wikidata	https://www.wikidata.org/wiki/Q103537
concepts[11].display_name	Antigen
concepts[12].id	https://openalex.org/C104317684
concepts[12].level	2
concepts[12].score	0.14105314016342163
concepts[12].wikidata	https://www.wikidata.org/wiki/Q7187
concepts[12].display_name	Gene
concepts[13].id	https://openalex.org/C2776914184
concepts[13].level	2
concepts[13].score	0.12577149271965027
concepts[13].wikidata	https://www.wikidata.org/wiki/Q101991
concepts[13].display_name	Inflammation
concepts[14].id	https://openalex.org/C2779134260
concepts[14].level	2
concepts[14].score	0.07405099272727966
concepts[14].wikidata	https://www.wikidata.org/wiki/Q12136
concepts[14].display_name	Disease
concepts[15].id	https://openalex.org/C99454951
concepts[15].level	1
concepts[15].score	0.0
concepts[15].wikidata	https://www.wikidata.org/wiki/Q932068
concepts[15].display_name	Environmental health
keywords[0].id	https://openalex.org/keywords/anti-neutrophil-cytoplasmic-antibody
keywords[0].score	0.7843469381332397
keywords[0].display_name	Anti-neutrophil cytoplasmic antibody
keywords[1].id	https://openalex.org/keywords/myeloperoxidase
keywords[1].score	0.7045552730560303
keywords[1].display_name	Myeloperoxidase
keywords[2].id	https://openalex.org/keywords/allele
keywords[2].score	0.6580836772918701
keywords[2].display_name	Allele
keywords[3].id	https://openalex.org/keywords/human-leukocyte-antigen
keywords[3].score	0.6099387407302856
keywords[3].display_name	Human leukocyte antigen
keywords[4].id	https://openalex.org/keywords/vasculitis
keywords[4].score	0.5839023590087891
keywords[4].display_name	Vasculitis
keywords[5].id	https://openalex.org/keywords/medicine
keywords[5].score	0.5176210999488831
keywords[5].display_name	Medicine
keywords[6].id	https://openalex.org/keywords/immunology
keywords[6].score	0.5101009011268616
keywords[6].display_name	Immunology
keywords[7].id	https://openalex.org/keywords/population
keywords[7].score	0.45531803369522095
keywords[7].display_name	Population
keywords[8].id	https://openalex.org/keywords/genetics
keywords[8].score	0.2462717890739441
keywords[8].display_name	Genetics
keywords[9].id	https://openalex.org/keywords/internal-medicine
keywords[9].score	0.22911453247070312
keywords[9].display_name	Internal medicine
keywords[10].id	https://openalex.org/keywords/biology
keywords[10].score	0.200630784034729
keywords[10].display_name	Biology
keywords[11].id	https://openalex.org/keywords/antigen
keywords[11].score	0.15463414788246155
keywords[11].display_name	Antigen
keywords[12].id	https://openalex.org/keywords/gene
keywords[12].score	0.14105314016342163
keywords[12].display_name	Gene
keywords[13].id	https://openalex.org/keywords/inflammation
keywords[13].score	0.12577149271965027
keywords[13].display_name	Inflammation
keywords[14].id	https://openalex.org/keywords/disease
keywords[14].score	0.07405099272727966
keywords[14].display_name	Disease
language	en
locations[0].id	doi:10.6084/m9.figshare.21876159.v2
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version
locations[0].raw_type	dataset
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	False
locations[0].is_published
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.6084/m9.figshare.21876159.v2
indexed_in	datacite
authorships[0].author.id	https://openalex.org/A5060659652
authorships[0].author.orcid	https://orcid.org/0000-0002-5142-5610
authorships[0].author.display_name	Aya Kawasaki
authorships[0].author_position	first
authorships[0].raw_author_name	Aya Kawasaki
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5042962574
authorships[1].author.orcid	https://orcid.org/0000-0003-1020-0818
authorships[1].author.display_name	Ken‐ei Sada
authorships[1].author_position	middle
authorships[1].raw_author_name	Ken-Ei Sada
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5024013916
authorships[2].author.orcid
authorships[2].author.display_name	Premita Ari Kusumawati
authorships[2].author_position	middle
authorships[2].raw_author_name	Premita Ari Kusumawati
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5030963270
authorships[3].author.orcid	https://orcid.org/0000-0002-5169-0692
authorships[3].author.display_name	Fumio Hirano
authorships[3].author_position	middle
authorships[3].raw_author_name	Fumio Hirano
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5101968884
authorships[4].author.orcid	https://orcid.org/0000-0002-1939-3380
authorships[4].author.display_name	S Kobayashi
authorships[4].author_position	middle
authorships[4].raw_author_name	Shigeto Kobayashi
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5060555424
authorships[5].author.orcid	https://orcid.org/0000-0002-0233-7198
authorships[5].author.display_name	Kenji Nagasaka
authorships[5].author_position	middle
authorships[5].raw_author_name	Kenji Nagasaka
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5064918848
authorships[6].author.orcid	https://orcid.org/0000-0002-7181-7494
authorships[6].author.display_name	Takahiko Sugihara
authorships[6].author_position	middle
authorships[6].raw_author_name	Takahiko Sugihara
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5064973929
authorships[7].author.orcid	https://orcid.org/0000-0003-0709-4858
authorships[7].author.display_name	Nobuyuki Ono
authorships[7].countries	JP
authorships[7].affiliations[0].institution_ids	https://openalex.org/I135598925
authorships[7].affiliations[0].raw_affiliation_string	Kyushu University
authorships[7].institutions[0].id	https://openalex.org/I135598925
authorships[7].institutions[0].ror	https://ror.org/00p4k0j84
authorships[7].institutions[0].type	education
authorships[7].institutions[0].lineage	https://openalex.org/I135598925
authorships[7].institutions[0].country_code	JP
authorships[7].institutions[0].display_name	Kyushu University
authorships[7].author_position	middle
authorships[7].raw_author_name	Nobuyuki Ono
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Kyushu University
authorships[8].author.id	https://openalex.org/A5086768780
authorships[8].author.orcid	https://orcid.org/0000-0002-9966-6202
authorships[8].author.display_name	Takashi Fujimoto
authorships[8].author_position	middle
authorships[8].raw_author_name	Takashi Fujimoto
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5037755032
authorships[9].author.orcid	https://orcid.org/0000-0003-0064-4765
authorships[9].author.display_name	Makio Kusaoi
authorships[9].author_position	middle
authorships[9].raw_author_name	Makio Kusaoi
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5064110644
authorships[10].author.orcid	https://orcid.org/0000-0003-1729-2954
authorships[10].author.display_name	Naoto Tamura
authorships[10].author_position	middle
authorships[10].raw_author_name	Naoto Tamura
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5042778033
authorships[11].author.orcid
authorships[11].author.display_name	Yasuyoshi Kusanagi
authorships[11].author_position	middle
authorships[11].raw_author_name	Yasuyoshi Kusanagi
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5103184166
authorships[12].author.orcid	https://orcid.org/0000-0002-4122-2983
authorships[12].author.display_name	Kenji Itoh
authorships[12].author_position	middle
authorships[12].raw_author_name	Kenji Itoh
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5106082905
authorships[13].author.orcid
authorships[13].author.display_name	Takayuki Sumida
authorships[13].author_position	middle
authorships[13].raw_author_name	Takayuki Sumida
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5079821787
authorships[14].author.orcid	https://orcid.org/0000-0002-7407-0410
authorships[14].author.display_name	Kunihiro Yamagata
authorships[14].author_position	middle
authorships[14].raw_author_name	Kunihiro Yamagata
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5075427398
authorships[15].author.orcid	https://orcid.org/0000-0003-1503-6789
authorships[15].author.display_name	Hiroshi Hashimoto
authorships[15].author_position	middle
authorships[15].raw_author_name	Hiroshi Hashimoto
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5101668258
authorships[16].author.orcid	https://orcid.org/0000-0002-1559-3799
authorships[16].author.display_name	Hirofumi Makino
authorships[16].author_position	middle
authorships[16].raw_author_name	Hirofumi Makino
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5032065165
authorships[17].author.orcid	https://orcid.org/0000-0002-6160-1382
authorships[17].author.display_name	Yoshihiro Arimura
authorships[17].author_position	middle
authorships[17].raw_author_name	Yoshihiro Arimura
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5010908061
authorships[18].author.orcid	https://orcid.org/0000-0002-6418-2603
authorships[18].author.display_name	Masayoshi Harigai
authorships[18].countries	JP
authorships[18].affiliations[0].institution_ids	https://openalex.org/I4210136522
authorships[18].affiliations[0].raw_affiliation_string	Tokyo Women's Medical University
authorships[18].institutions[0].id	https://openalex.org/I4210136522
authorships[18].institutions[0].ror	https://ror.org/03kjjhe36
authorships[18].institutions[0].type	education
authorships[18].institutions[0].lineage	https://openalex.org/I4210136522
authorships[18].institutions[0].country_code	JP
authorships[18].institutions[0].display_name	Tokyo Women's Medical University
authorships[18].author_position	middle
authorships[18].raw_author_name	Masayoshi Harigai
authorships[18].is_corresponding	False
authorships[18].raw_affiliation_strings	Tokyo Women's Medical University
authorships[19].author.id	https://openalex.org/A5000894813
authorships[19].author.orcid	https://orcid.org/0000-0002-6776-5580
authorships[19].author.display_name	Naoyuki Tsuchiya
authorships[19].author_position	last
authorships[19].raw_author_name	Naoyuki Tsuchiya
authorships[19].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.6084/m9.figshare.21876159.v2
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary materials for the manuscript "Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population"
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T06:51:31.235846
primary_topic.id	https://openalex.org/T10697
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9994000196456909
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2740
primary_topic.subfield.display_name	Pulmonary and Respiratory Medicine
primary_topic.display_name	Vasculitis and related conditions
related_works	https://openalex.org/W179552849, https://openalex.org/W2398608410, https://openalex.org/W2003751215, https://openalex.org/W1981782668, https://openalex.org/W2070931144, https://openalex.org/W2041291439, https://openalex.org/W2079913949, https://openalex.org/W1591303294, https://openalex.org/W4386995819, https://openalex.org/W2376034126
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.6084/m9.figshare.21876159.v2
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version
best_oa_location.raw_type	dataset
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	False
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.6084/m9.figshare.21876159.v2
primary_location.id	doi:10.6084/m9.figshare.21876159.v2
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version
primary_location.raw_type	dataset
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	False
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.6084/m9.figshare.21876159.v2
publication_date	2023-01-01
publication_year	2023
referenced_works_count	0
abstract_inverted_index.1.	129, 133
abstract_inverted_index.2.	150
abstract_inverted_index.ID	112, 116, 122
abstract_inverted_index.II	156
abstract_inverted_index.as	124
abstract_inverted_index.by	107
abstract_inverted_index.in	126, 139
abstract_inverted_index.of	5, 11, 23, 29, 41, 47, 59, 65, 90, 103, 152
abstract_inverted_index.to	15, 33, 51, 69, 88
abstract_inverted_index.HLA	137, 154
abstract_inverted_index.S1.	2, 74
abstract_inverted_index.S2.	20
abstract_inverted_index.S3.	38
abstract_inverted_index.S4.	56
abstract_inverted_index.The	96
abstract_inverted_index.and	13, 31, 49, 67, 118, 136, 145
abstract_inverted_index.are	94
abstract_inverted_index.for	143
abstract_inverted_index.the	79, 91
abstract_inverted_index.was	109
abstract_inverted_index.156)	117
abstract_inverted_index.36),	113
abstract_inverted_index.<br>	17, 35, 53, 71, 130, 147, 162
abstract_inverted_index.Data	128, 132, 149
abstract_inverted_index.acid	158
abstract_inverted_index.each	6, 24, 42, 60, 89, 104, 140, 153
abstract_inverted_index.tags	99
abstract_inverted_index.time	14, 32, 50, 68
abstract_inverted_index.with	9, 27, 45, 63, 159
abstract_inverted_index.164),	123
abstract_inverted_index.Table	1, 19, 37, 55
abstract_inverted_index.amino	157
abstract_inverted_index.shown	125
abstract_inverted_index.three	92
abstract_inverted_index.-class	155
abstract_inverted_index.Figure	73
abstract_inverted_index.Sanger	75, 84
abstract_inverted_index.allele	8, 26, 44, 62, 98
abstract_inverted_index.around	78
abstract_inverted_index.shown.	95
abstract_inverted_index.tagSNP	81
abstract_inverted_index.relapse	12, 30, 48, 66
abstract_inverted_index.subject	105, 141
abstract_inverted_index.(relapse	111, 121
abstract_inverted_index.Clinical	134
abstract_inverted_index.PCR-SSOP	108
abstract_inverted_index.analysis	4, 22, 40, 58
abstract_inverted_index.examined	142
abstract_inverted_index.relapse.	16, 34, 52, 70, 146
abstract_inverted_index.genotypes	93, 138
abstract_inverted_index.survival.	161
abstract_inverted_index.determined	106
abstract_inverted_index.occurrence	10, 28, 46, 64
abstract_inverted_index.sequencing	76, 85
abstract_inverted_index.Association	3, 21, 39, 57, 151
abstract_inverted_index.information	135
abstract_inverted_index.rs11545686.	82
abstract_inverted_index.rs11545686C	97
abstract_inverted_index.<em>HLA-DQA1	101
abstract_inverted_index.relapse-free	160
abstract_inverted_index.(</em>relapse	115
abstract_inverted_index.</em>genotype	102
abstract_inverted_index.Supplementary	0, 18, 36, 54, 72, 127, 131
abstract_inverted_index.chromatograms	77, 86
abstract_inverted_index.corresponding	87
abstract_inverted_index.<em>DQA1*</em>	119
abstract_inverted_index.Representative	83
abstract_inverted_index.Susceptibility	148
abstract_inverted_index.susceptibility	144
abstract_inverted_index.<em>HLA-DPB1</em>	61
abstract_inverted_index.<em>HLA-DQA1</em>	25
abstract_inverted_index.<em>HLA-DQB1</em>	43
abstract_inverted_index.<em>HLA-DRB1</em>	7
abstract_inverted_index.<em>01:01/01:02</em>	120
abstract_inverted_index.<em>DQA1*03:02/05:07	114
abstract_inverted_index.<em>HLA-DQA1*03:02</em>	80
abstract_inverted_index.<em>HLA-DQA1*03:02.</em>	100
abstract_inverted_index.<em>DQA103:02/0302</em>	110
cited_by_percentile_year
countries_distinct_count	1
institutions_distinct_count	20
citation_normalized_percentile